September 9, 2019– Congress is back in town this week after the end of its August recess, and lawmakers are gearing up for a busy fall with a major focus on how to slow down ever-increasing drug prices. The cost of prescription drugs is on the minds of members from both parties in Congress as well as members of the Trump administration. Before they left town, two Senate … [Read more...]
340B Key to Trump Administration’s HIV Strategy
April 25, 2019— President Trump’s ambitious campaign to end the HIV epidemic in the U.S. will rely heavily on the 340B drug pricing program, according to senior administration officials. A key focus of the effort is to connect people at risk of HIV infection to pre-exposure prophylaxis (PrEP), a treatment that can cost nearly $2,000 a month. In his State of the Union … [Read more...]